Back

Hybrid vascular interventin for multilevel peripheral arterial disease

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Diseases of the Aorta ePosters Intervention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Petr Puzdriak

2 City Hospital, Saint Petersburg (Russian Federation)

25 More presentations in this session

Presentation thumbnail
The effect of doxycycline on abdominal aortic aneurysm growth: a meta-analysis.
Doctor M. Patel (Toledo, US)
Abstract Slides
Presentation thumbnail
Early and mid-term outcomes of modified aortic root repair for acute stanford type A aortic dissection
Doctor L. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Aortic tortuosity is related to aortic phenotype in patients with bicuspid aortic valve: a CT scan study of 83 cases.
Mr T. Wallet (Paris, FR)
Abstract Slides
Presentation thumbnail
Prognostic significance of polyvascular disease in patients admitted with acute decompensated heart failure: The ARIC Study Community Surveillance
Doctor Z. Chunawala (Rochester, US)
Abstract Slides
Presentation thumbnail
Neointimal hyperplasia regression using combined paclitaxel- mediated confocal dual pulse shock wave sonoporation therapy and catheter- based 90Y- mediated brachytherapy
Doctor H. Mehrad (Tabriz, IR)
Abstract Slides

Access the full session

Session thumbnail
Diseases of the Aorta ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
2 September 2024
thumbnail
Congress Presentation
Impact of revascularization of complex coronary disease in patients with chronic coronary disease: are we being too invasive?
29 June 2021
thumbnail
Congress Presentation
Endovascular treatment of peripheral artery disease is associated with improved central hemodynamics and ventricular function
28 August 2020
thumbnail
Congress Presentation
Hybrid coronary revascularization versus PCI for the treatment of high-risk patients with multivessel coronary artery disease: 2-year follow-up results from two institutions
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources